[1]
“Sorafenib for the treatment of hepatocellular carcinoma: a single-centre real-world study”, Radiol Oncol, vol. 54, no. 2, pp. 233–236, May 2020, Accessed: Oct. 23, 2026. Available: https://www.radioloncol.com/index.php/ro/article/view/3362